MX2009005351A - Compuestos utiles para tratar trastornos neurodegenerativos. - Google Patents

Compuestos utiles para tratar trastornos neurodegenerativos.

Info

Publication number
MX2009005351A
MX2009005351A MX2009005351A MX2009005351A MX2009005351A MX 2009005351 A MX2009005351 A MX 2009005351A MX 2009005351 A MX2009005351 A MX 2009005351A MX 2009005351 A MX2009005351 A MX 2009005351A MX 2009005351 A MX2009005351 A MX 2009005351A
Authority
MX
Mexico
Prior art keywords
compounds useful
neurodegenerative disorders
treating neurodegenerative
treating
lessening
Prior art date
Application number
MX2009005351A
Other languages
English (en)
Spanish (es)
Inventor
Mark A Findeis
Original Assignee
Satori Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Satori Pharmaceuticals Inc filed Critical Satori Pharmaceuticals Inc
Publication of MX2009005351A publication Critical patent/MX2009005351A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D335/00Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
    • C07D335/04Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J71/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005Oxygen-containing hetero ring
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/34Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom
    • A01N43/40Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom six-membered rings
    • A01N43/42Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom six-membered rings condensed with carbocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/12Ophthalmic agents for cataracts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Ophthalmology & Optometry (AREA)
  • Psychology (AREA)
  • Pest Control & Pesticides (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Obesity (AREA)
  • Agronomy & Crop Science (AREA)
  • Wood Science & Technology (AREA)
  • Dentistry (AREA)
  • Plant Pathology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
MX2009005351A 2006-11-20 2006-11-20 Compuestos utiles para tratar trastornos neurodegenerativos. MX2009005351A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2006/044880 WO2008063165A1 (en) 2006-11-20 2006-11-20 Compounds useful for treating neurodegenerative disorders

Publications (1)

Publication Number Publication Date
MX2009005351A true MX2009005351A (es) 2009-06-08

Family

ID=39429980

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009005351A MX2009005351A (es) 2006-11-20 2006-11-20 Compuestos utiles para tratar trastornos neurodegenerativos.

Country Status (10)

Country Link
EP (1) EP2073637A4 (pt)
JP (1) JP2010510309A (pt)
KR (1) KR20090087075A (pt)
CN (1) CN101610673A (pt)
AU (1) AU2006350960B2 (pt)
BR (1) BRPI0622138A2 (pt)
CA (1) CA2670276A1 (pt)
IL (1) IL198856A0 (pt)
MX (1) MX2009005351A (pt)
WO (1) WO2008063165A1 (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI433674B (zh) 2006-12-28 2014-04-11 Infinity Discovery Inc 環杷明(cyclopamine)類似物類
US7990394B2 (en) 2007-05-25 2011-08-02 Google Inc. Viewing and navigating within panoramic images, and applications thereof
AU2010279325B2 (en) 2009-08-05 2016-10-20 Infinity Pharmaceuticals, Inc. Enzymatic transamination of cyclopamine analogs
US9394313B2 (en) 2010-09-14 2016-07-19 Infinity Pharmaceuticals, Inc. Transfer hydrogenation of cyclopamine analogs
PL3302428T3 (pl) 2015-06-04 2026-04-13 Sol-Gel Technologies Ltd. Preparaty do zastosowania miejscowego do dostarczania związków inhibitora hedgehog i ich zastosowanie
US10217283B2 (en) 2015-12-17 2019-02-26 Google Llc Navigation through multidimensional images spaces
US10245091B2 (en) 2015-12-30 2019-04-02 Exsomed Holding Company, Llc Dip fusion spike screw
CN107281206A (zh) * 2016-03-30 2017-10-24 南京惠宝生物医药有限公司 黑升麻苷在制备防治老年性痴呆药物中的应用
KR102120376B1 (ko) * 2018-05-28 2020-06-09 한국과학기술연구원 승마 추출물, 이의 분획물 또는 승마에서 유래된 화합물을 유효성분으로 포함하는 퇴행성 뇌질환의 예방 또는 치료용 조성물
CN109528738A (zh) * 2018-12-24 2019-03-29 陕西师范大学 甘草酸在制备促进髓鞘再生抑制神经炎症药物的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030060425A1 (en) * 1998-11-24 2003-03-27 Ahlem Clarence N. Immune modulation method using steroid compounds
GB9923077D0 (en) * 1999-09-29 1999-12-01 Phytopharm Plc Sapogenin derivatives and their use
CN100430062C (zh) * 2002-03-15 2008-11-05 萨马里坦药品公司 神经保护性螺甾烯醇药用组合物
US7851641B2 (en) * 2005-05-17 2010-12-14 Satori Pharmaceuticals, Inc. Compounds useful for treating neurodegenerative disorders

Also Published As

Publication number Publication date
AU2006350960B2 (en) 2013-09-12
BRPI0622138A2 (pt) 2011-12-27
CA2670276A1 (en) 2008-05-29
EP2073637A1 (en) 2009-07-01
AU2006350960A1 (en) 2008-05-29
JP2010510309A (ja) 2010-04-02
WO2008063165A1 (en) 2008-05-29
IL198856A0 (en) 2010-02-17
CN101610673A (zh) 2009-12-23
KR20090087075A (ko) 2009-08-14
EP2073637A4 (en) 2011-12-28

Similar Documents

Publication Publication Date Title
WO2008130449A3 (en) Modulators of amyloid-beta production
EA200971050A1 (ru) Способы лечения и предупреждения нейродегенеративных заболеваний и нарушений
MXPA05012680A (es) Indoles novedosos de 3-azufre sustituidos.
WO2009127642A3 (en) Use of lrrk2 inhibitors for neurodegenerative diseases
TW200510303A (en) Novel compounds
TW200612892A (en) Novel compounds
MX2007012374A (es) Metodos y composiciones para el tratamiento de condiciones relacionadas con cns.
WO2007138282A3 (en) Bi-aryl or aryl-heteroaryl substituted indoles
WO2009025785A3 (en) Cb2 receptor ligands for the treatment of pain
WO2010075280A3 (en) Coumarin-based compounds for the treatment of alzheimer's disease and cancer
DE502004003249D1 (en) (s)-2-n-propylamino-5-hydroxytetralin als d3-agonistisches therapeutikum
ATE543494T1 (de) Griseofulvin-analoga zur behandlung von krebs durch hemmung von zentrosomaler clusterbildung
MX2009003981A (es) Agentes moduladores del receptor de calcio.
MX368459B (es) Nuevas composiciones para prevenir y/o tratar trastornos degenerativos del sistema nervioso central.
TW200745003A (en) Novel compounds
MX2012010084A (es) Compuestos utiles para tratar transtornos neurodegenerativos.
WO2008136863A3 (en) Synthesis of compounds useful as modulators of amyloid-beta production
EA201001586A1 (ru) Соединения и композиции в качестве ингибиторов itpkb
IL185410A0 (en) Use of 2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-cyclohexanedione in the treatment of parkinson's disease
MX2009005351A (es) Compuestos utiles para tratar trastornos neurodegenerativos.
PT1778837E (pt) Tratamento de doenças neurodegenerativas por utilização de inibidores de scd4
MX2007011847A (es) Derivados de pirimidindiona como antagonistas del receptor de procineticina 2.
TW200642690A (en) Composition for treating central nervous system disorders
TW200602297A (en) Sulfonamide compounds for the treatment of neurodegenerative disorders
TW200744577A (en) Method for treating osteoarthritis

Legal Events

Date Code Title Description
FA Abandonment or withdrawal